Acquired decrease in sensitivity to quinine observed during studies with a strain of chloroquine-resistant Plasmodium falciparum.
D000328:Adult; D002738:Chloroquine / Q000494:pharmacology*; D004352:Drug Resistance, Microbial; D006801:Humans; D008288:Malaria / Q000188:drug therapy / Q000209:etiology / Q000382:microbiology; D008297:Male; D010963:Plasmodium falciparum / Q000187:drug effects* / Q000302:isolation & purification; D011739:Pyrimethamine / Q000008:administration & dosage / Q000627:therapeutic use; D011803:Quinine / Q000008:administration & dosage / Q000494:pharmacology* / Q000627:therapeutic use; D012008:Recurrence; D013411:Sulfadiazine / Q000008:administration & dosage / Q000627:therapeutic use; D013997:Time Factors
D013411:Sulfadiazine; D002738:Chloroquine; D011803:Quinine; D011739:Pyrimethamine